Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Return on Sales (2017 - 2019)

Historic Return on Sales for Iterum Therapeutics (ITRM) over the last 3 years, with Q4 2019 value amounting to 2800.38%.

  • Iterum Therapeutics' Return on Sales fell 26988800.0% to 2800.38% in Q4 2019 from the same period last year, while for Dec 2019 it was 2800.38%, marking a year-over-year decrease of 27117100.0%. This contributed to the annual value of 7.59% for FY2024, which is 51400.0% down from last year.
  • Iterum Therapeutics' Return on Sales amounted to 2800.38% in Q4 2019, which was down 26988800.0% from 375.89% recorded in Q3 2019.
  • Iterum Therapeutics' 5-year Return on Sales high stood at 26.13% for Q4 2017, and its period low was 2800.38% during Q4 2019.
  • Moreover, its 3-year median value for Return on Sales was 99.77% (2018), whereas its average is 434.2%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -466600bps in 2018, then crashed by -26988800bps in 2019.
  • Over the past 3 years, Iterum Therapeutics' Return on Sales (Quarter) stood at 26.13% in 2017, then tumbled by -288bps to 101.49% in 2018, then tumbled by -2659bps to 2800.38% in 2019.
  • Its Return on Sales stands at 2800.38% for Q4 2019, versus 375.89% for Q3 2019 and 183.74% for Q2 2019.